Press monitoring
Bacteria, plants could help modernize flu shots
4.5.2006 | Press monitoring
CLEVELAND (Reuters) - Turning bacteria, plants or insect cells into protein factories could be a key to faster vaccine production to fight a flu pandemic or another outbreak, vaccine developers and U.S. scientists said on Tuesday.
Nanogen Earns Two Patents for Therapeutic and Diagnostic Use of Biomarkers
3.5.2006 | Press monitoring
Nanogen, Inc. (NASDAQ: NGEN), developer of advanced diagnostic products, announced today that it has been issued two patents by the U.S. Patent and Trademark Office for inventions related to disease biomarkers.
Protein map raises hopes for schistosomiasis drugs
3.5.2006 | Press monitoring
Chinese scientists have identified thousands of proteins that are crucial to a parasitic worm that infects more than a million people in China and parts of South-East Asia.
Microfluidics showcase nanoparticle products at Interphex
2.5.2006 | Press monitoring
Nanoparticle product provider Microfluidics has used this year’s Interphex show to introduce products based on its Microfluidizer processor technology, providing solutions for laboratory and manufacturing applications that use nanoparticle measurements.
Scientists seek biotech answer to hunger
2.5.2006 | Press monitoring
KANSAS CITY, Missouri (Reuters) - As he pores over plant tissue and petri dishes in a biotech seed lab in Johnston, Iowa, Luke Mehlo is half a world away from his home in South Africa.
Pharmacogenomic Testing and Regulation: The Role of Pharmacogenomics in Pharmaceutical Development and the Regulation of Pharmacogenetic Test as In Vitro Diagnostics
2.5.2006 | Press monitoring
This article reviews the current role and future trends of pharmacogenomic testing in pharmaceutical development and postmarketing surveillance. The regulatory controls operating in Europe and the United States are described and compared. It is suggested that codevelopment of the diagnostic test should be considered as an integral part of the drug...
Poland may approve gene crop ban despite EU
1.5.2006 | Press monitoring
Poland's upper house of parliament may ban trade and plantings of genetically modified (GMO) seeds on Thursday and put Warsaw on a collision course with Brussels for endorsing a law that breaks EU rules.
U.K. Team Targets Viruses With Nanomaterials
30.4.2006 | Press monitoring
A consortium led by QinetiQ Nanomaterials Ltd. (QNL), a subsidiary of the U.K. firm QinetiQ, will develop a range of nanomaterials for use in the fight against a broad spectrum of viruses. A two-year program is being funded by the Southeast England Development Agency, which has allocated $3.5 million to the project.
Comparison of Schizophrenia Drugs Often Favors Firm Funding Study
29.4.2006 | Press monitoring
Pharmaceutical giant Eli Lilly and Co. recently funded five studies that compared its antipsychotic drug Zyprexa with Risperdal, a competing drug made by Janssen. All five showed Zyprexa was superior in treating schizophrenia.
